Conference abstract · 27 Oct 2014
Conference abstract
Occurrence of adverse drug reactions in the paediatric population
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he safety of prescribed medicines is an important public health issue because serious adverse drug reactions (ADRs) may occur. Medicines are prescribed to children, although many drugs have been marketed with no or limited experience regarding the effi cacy and safety in this population. Very few clinical trials involving children have focused on the effi cacy of medicines and rarely have they covered safety. Th e aim of this presentation is to present fi ndings with respect to occurrence, seriousness and type of reported ADR, therapeutic group, age and gender of the child and category of reporter. Th e empirical analyses were based on registration fi les, published articles and ADR reports submitted to the national Danish ADR database. We analyzed 4500 ADRs submitted for children from ages 0 to 17 years to the Danish national ADR database from 1998 to 2007 and approximately 40% of these were serious. One-half of ADRs were reported in children from 0 up to 2 years of age. Approximately 17% of reported ADRs were associated with off -label use, 60% of them serious. Th e majority of ADRs were reported for immunization and antibiotics and psychotropic medicine. Serious ADRs due to off -label prescribing are more likely to be reported for hormonal contraceptives, anti-acne preparations and allergens. Th e majority of ADRs were reported by physicians. In conclusion there is a need for more research into the prescribing of medicines in the teenage population, as well as tighter reporting and monitoring of ADRs for medicines prescribed off -label
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 27 May 2021
Adverse Drug Events: Untoward Medical Occurrence
Conference abstract · 30 Jan 2017
Dexmedetomidine population pharmacokinetics, adverse reactions and their relationship with blood levels in pediatric patients
Article · 19 Jun 2026
Improving Patient Care Through Comprehensive Adverse Drug Reaction Assessment
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Lise Aagaard”
